NYR Insider Trading

Insider Ownership Percentage: 38.11%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Nyrada Insider Trading History Chart

This chart shows the insider buying and selling history at Nyrada by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Nyrada Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for NYR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Nyrada Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/12/2024John MooreInsiderIssued1,333,333A$0.08A$99,999.98
3/14/2024Christopher CoxInsiderExpiry600,000A$0.10A$60,000.00
6/29/2021Ruediger WeselohInsiderIssued100,000A$0.26A$26,000.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Nyrada (ASX:NYR)

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurodegenerative diseases. Its products in the drug development stage includes PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; and neuroprotectant drug to reduce the disability in patients with traumatic brain injury and ischaemic stroke. Nyrada Inc. was incorporated in 2017 and is based in Gordon, Australia.
Read More on Nyrada

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

65,000 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54

Who are the company insiders with the largest holdings of Nyrada?

Nyrada's top insider investors include:
  1. Christopher Cox (Insider)
  2. John Moore (Insider)
Learn More about top insider investors at Nyrada.